gptkbp:instanceOf
|
alkaloid
Hallucinogen
|
gptkbp:actsOn
|
serotonin receptor agonist
|
gptkbp:ATCCode
|
none
|
gptkbp:CASNumber
|
520-52-5
|
gptkbp:category
|
gptkb:indole_alkaloids
phenols
serotonin receptor agonists
psychedelic tryptamines
|
gptkbp:chemicalFormula
|
C12H16N2O
|
gptkbp:color
|
white to off-white (pure)
|
gptkbp:degradedBy
|
air
heat
light
|
gptkbp:discoveredBy
|
gptkb:Albert_Hofmann
|
gptkbp:discoveredIn
|
1958
|
gptkbp:foundIn
|
Psilocybe mushrooms
|
https://www.w3.org/2000/01/rdf-schema#label
|
psilocin
|
gptkbp:IUPACName
|
4-hydroxy-N,N-dimethyltryptamine
|
gptkbp:legalStatus
|
gptkb:Schedule_III_(Canada)
gptkb:Schedule_I_(US)
gptkb:Class_A_(UK)
|
gptkbp:meltingPoint
|
173–176 °C
|
gptkbp:metabolite_of
|
psilocybin
|
gptkbp:molecularWeight
|
204.27 g/mol
|
gptkbp:PubChem_CID
|
10624
CHEBI:8614
10186
CHEMBL391
|
gptkbp:relatedTo
|
gptkb:DMT
gptkb:bufotenin
psilocybin
|
gptkbp:routeOfAdministration
|
oral
intramuscular
intravenous
insufflation
|
gptkbp:solubility
|
slightly soluble in water
|
gptkbp:UNII
|
4UFQ3UFV8V
|
gptkbp:usedFor
|
psychedelic effects
|
gptkbp:bfsParent
|
gptkb:Gymnopilus_junonius
gptkb:Panaeolus_cinctulus
gptkb:Pluteus_salicinus
gptkb:Psilocybe_cubensis
gptkb:Psilocybe_cyanescens
gptkb:Psilocybe_semilanceata
|
gptkbp:bfsLayer
|
5
|